Title of article :
[188Re]Rhenium Sulfide Suspension: A Potential Radiopharmaceutical for Tumor Treatment Following Intra-Tumor Injection
Author/Authors :
Junfeng، Yu نويسنده , , Duanzhi، Yin نويسنده , , Xiaofeng، Min نويسنده , , Zili، Guo نويسنده , , ZhangJiong، نويسنده , , Yongxian، Wang نويسنده , , Jr، F.F. Knapp نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1999
Pages :
-572
From page :
573
To page :
0
Abstract :
Amajor liabilitv facing the owners and operators of nuclear facilities worldwide is the decontamination and decommissioning ( D& D ) of contaminated massive concrete structures. A biodecontamination technology which harnesses the action of naturally occurring bacteria is currently under joint development by BNFL and the Idaho National Engineering and Environmental Laboratory. This emerging technology was judged to exhibit advantages in cost, worker health and safety risk reduction, and programmatic effectiveness. The process takes approximately six months to one year to remove the contaminated surface and can advantageously be applied during the care and maintenance phase of a D&D programme. A detailed assessment of the biodecontamination process in relation to the next best and base technologies was performed. The findings of this study, which recommended a large-scale technology demonstration, will be presented.
Keywords :
Tumor-inhibiting ratio , Intra-tumor injection , biodistribution , suspension
Journal title :
NUCLEAR MEDICING & BIOLOGY
Serial Year :
1999
Journal title :
NUCLEAR MEDICING & BIOLOGY
Record number :
29474
Link To Document :
بازگشت